NCT02253823View on ClinicalTrials.gov

Multiple Dose Comparison of the Effect of Two Dose Combinations of Tipranavir/Ritonavir (TPV/RTV), on the Pharmacokinetic Characteristics of Efavirenz (Sustiva®) in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

March 31, 2002

Conditions
Healthy
Interventions
DRUG

EFV

DRUG

TPV/RTV - low dose

DRUG

TPV/RTV - high dose

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02253823 - Multiple Dose Comparison of the Effect of Two Dose Combinations of Tipranavir/Ritonavir (TPV/RTV), on the Pharmacokinetic Characteristics of Efavirenz (Sustiva®) in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter